WHO Register of non-State actors

Disclaimer:

Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

Overview

Official name

World Federation for Ultrasound in Medicine and Biology, Inc.

Acronym (if applicable)

WFUMB

Short self description

The World Federation for Ultrasound in Medicine and Biology (WFUMB) is dedicated to the advancement of ultrasound by encouraging research, promoting international cooperation, disseminating scientific information, and improving communication and understanding in the world community using ultrasound in medicine and biology.

Website

http://www.wfumb.org

Web link to health relevant activities

Parent entity (if applicable)

The entity you represent is indicated as a parent of the following entities in the Register:

N / A

Date submitted

10 Sep 2024 06:26:33 PM

General information

Name

Official name

World Federation for Ultrasound in Medicine and Biology, Inc.

Acronym (if applicable)

WFUMB

Commonly used name (if applicable)

World Federation for Ultrasound in Medicine and Biology

Names in other official languages (if applicable) Name Abbreviation

Former name

Short self description

Address

Address 1

Office address

Address 2

PO Box 72718

Address 3

Town/City

London

State/Region

London

Postal code

SW19 9HD

Country

United Kingdom of Great Britain and Northern Ireland (The)

Related links

Website

http://www.wfumb.org

Governance

Legal status

Nonprofit Organization

Year established

1973

Governance structure

Description of main decision making bodies (e.g. board, board of directors, executive board, executive committee, etc).

Name of body

Executive Bureau

Composition and current list of members Name Function Affiliation

Prof Maria Cristina Chammas MD

Immediate Past President 2023 - 2025

Director of Ultrasound Division, Department of Radiology - Hospital das Clínicas, School of Medicine, University of São Paulo, São Paulo, Brazil

Prof George Condous

President Elect 2023 - 2025

Associate Professor of Gynaecology, Acute Gynaecology, Early Pregnancy and Advanced Endosurgery Unit, Sydney Medical School Nepean, University of Sydney, Australia

Prof Christoph F Dietrich

Treasurer 2021-2024

Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem and Permancence, 3013 Bern, Switzerland

Prof Sudhir Vinayak

President 2023 - 2025

Radiologist, Aga Khan University, Nairobi, Kenya

Prof Ioan Sporea

Vice President 1 2023 - 2025

Department of Gastroenterology, Victor Babes University Timisoara, Romania

Prof Iwaki Akiyama

Honorary Secretary 2023 - 2025

Doshisha University Medical Ultrasound Research Center, Kyoto, Japan

Prof Antonio Matteoni

Vice President 2 2023 - 2025

Radiologist Hospital de Clínicas of the Federal University of Bahia, Brazil

Functions

All decisions regarding policy and activities of the Federation.

Name of body

Administrative Council

Composition and current list of members Name Function Affiliation

Won Jae Lee, MD

AFSUMB Representative

Professor, Radiology, Sung Kyn Kwan University School of Medicine, Seoul, Republic of Korea

Alison Deslandes

ASUM Representative

Sonographer Specialist Imaging Partners, Adelaide, Australia

Christian Jenssen

EFSUMB Representative

Professor, Gastroentrology, Hospital Märkisch Oderland, Germany

Edda Chaves

FLAUS Representative

Radiology Service Hospital Nicolás Solano La Chorrera Panama Oeste, Panama

Hassen Gharbi

MASU Francophone Representative

Professor of pediatric radiology, Tunis, Tunisia

Yung Liang Wan

Co-opted

Radiologist, Linkou Chang Gung Memorial Hospital, Taiwan, China

Jo McCann

Co-opted

Sonographer Te Whatu Ora- Hutt Valley, New Zealand

Saqar Altai

Co-opted

Radiologist, Royal Hospital, Ministry of Health, Muscat, Sultanate of Oman

Functions

Represent each of the federations in Europe, Asia, Australasia, Africa, Latin and South America to advise on policy and approve activities.

General Assembly

Does the entity have a General Assembly of members or a similar body?

Yes

Name

General Assembly

Composition

8 members representatives of the five federations represented in WFUMB who are voting members and 3 co-opted members who meet with the Executive Bureau.

Functions

All decisions regarding policy, changes to constitution, activities and review of the Federation.

Financial information

Latest available annual income (month/year)

From

January

2023

December

2023

Annual income (USD)

346,096

Latest available assets (month/year)

As of

July

2024

Total assets (USD)

4,582,557

Income sources (in USD)

Income source Income type

Private sector entities (including business associations)

Philanthropic foundations

NGOs, academic institutions

Government entities, intergovernmental organizations, including UN

General public, individuals

Total

Sales of goods and services *

276,680

Grants / Donations

In-kind donations

Membership fees

69,416

Investment income

Others

Total

346,096

* income from congresses / conferences should be listed under Sales of goods and services

Additional information

Congress income 0 USD for WFUMB 2023. Income under sale of goods and services royalties from journal of ultrasound (Ultrasound in Medicine and Biology, UMB).

Membership

Entity's members

Is the entity you represent membership based?

Yes

Overview of categories and their voting rights in the main governing body:

Total number Voting

Individuals

47,362

NGOs

Private sector entities

Philanthropic foundations

Academic institutions

Government entities

Intergovernmental organizations

Organizational Structure

Parent entity

In the register Registered Entity Entity Name

No data available

Yes

WFUMB

Legal status

Not for profit organisation

Affiliated entities (or subsidiaries)

In the register Registered Entity Entity Name

No data available

Yes

Asian Federation for Ultrasound in Medicine and Biology (AFSUMB)

Yes

Australasian Society for Ultrasound in Medicine (ASUM)

Yes

European Federation for Ultrasound in Medicine and Biology (EFSUMB)

Yes

Federation of Latin American Ultrasound Societies (FLAUS)

Yes

Mediterranean and African Society of Ultrasound (MASU)

Relations

Entity's membership in other entities

In the register Registered Entity Entity Name Type of membership

No data available

Members of the entity

In the register Registered Entity Member Name

No data available

Yes

Activities

Aims (or purposes, objectives) of the entity as they appear in its constitution or by-laws or equivalent document.

The objectives of the Federation shall be scientific, literary, and educational. Its aims shall be to encourage research in the field; to promote international cooperation in the field; and to disseminate scientific information. In pursuit of these aims the Federation may, in relation to its specific field of interest, engage in the following activities: sponsorship of meetings; publication of an official journal and other official documents; cooperation with other societies and organizations in specific learning; appointment of commissions on special problems; awarding of prizes and distinctions. It may promote the formation of national or regional societies or groups, the coordination of bibliographic and informational services and the improvement of standards in terminology, equipment, methods and safety practices, and generally shall promote improved communication and understanding in the world community using ultrasound in medicine and biology.

The activities of the entity are related to the following strategic priorities and outcomes of the current WHO's General Programme of Work:

Strategic objective 1: Respond to climate change, an escalating health threat in the 21st century

Joint outcome 1.1. More climate-resilient health systems are addressing health risks and impacts

Joint outcome 1.2. Lower-carbon health systems and societies are contributing to health and well-being

Strategic objective 2: Address health determinants and the root causes of ill health in key policies across sectors

Joint outcome 2.1. Health inequities reduced by acting on social, economic, environmental and other determinants of health

Joint outcome 2.2. Priority risk factors for noncommunicable and communicable diseases, violence and injury, and poor nutrition, reduced through multisectoral approaches

Joint outcome 2.3. Populations empowered to control their health through health promotion programmes and community involvement in decision-making

Strategic objective 3: Advance the primary health care approach and essential health system capacities for universal health coverage

Joint outcome 3.1. The primary health care approach renewed and strengthened to accelerate universal health coverage

Joint outcome 3.2. Health and care workforce, health financing and access to quality-assured health products substantially improved

Joint outcome 3.3. Health information systems strengthened and digital transformation implemented.

Strategic objective 4: Improve health service coverage and financial protection to address inequity and gender inequalities

Joint outcome 4.1. Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance

Joint outcome 4.2. Equity in access to sexual, reproductive, maternal, newborn, child, adolescent and older person health and nutrition services and immunization coverage improved

Joint outcome 4.3. Financial protection improved by reducing financial barriers and out-of-pocket health expenditures, especially for the most vulnerable

Strategic objective 5: Prevent, mitigate and prepare for risks to health from all hazards

Joint outcome 5.1. Risks of health emergencies from all hazards reduced and impact mitigated

Joint outcome 5.2. Preparedness, readiness and resilience for health emergencies enhanced

Strategic objective 6: Rapidly detect and sustain an effective response to all health emergencies

Joint outcome 6.1. Detection of and response to acute public health threats is rapid and effective

Joint outcome 6.2. Access to essential health services during emergencies is sustained and equitable

Additional information on the entity's activities

Outreach programme for current 20 Centres of Education in Africa, Asia, Australasia, Europe, Latin and South America

Country presence

Countries where the entity has activities, members and regional offices / representatives:

Regions

Countries

Activities

Members

Offices / representatives

African Region

Region of the Americas

Eastern Mediterranean Region

European Region

South-East Asia Region

Western Pacific Region

Global

Disclosure & declaration

Tobacco/Arms related disclosure statement for non-State actors

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?

Yes

No

Unable to answer

To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.

Yes

No

Unable to answer

To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.

Yes

No

Unable to answer

If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.

By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.

Engagement with other industries affecting human health or affected by WHO norm and standards

Does the entity you represent have any formal association, affiliation or links with the following industry sectors?

If yes, please tick the box of the industry concerned and provide details in the space provided:

Alcohol

Chemical

Food and beverages

Health care

As needed relations (not formal association, affiliation or links) with multiple ultrasound manufacturers (e.g. GE, Philips, Samsung, Siemens, Canon, Mindray, SonoScape ) for financial help with projects in developing countries or educational courses cooperation (such as ultrasound machines loan).

Pharmaceutical

Others

Please specify industry

WHO Secretariat reserves the right to request additional information from the entity you represent relevant to its engagement with WHO.

*Sexual Exploitation, Abuse and Harassment (SEAH) and Misconduct (abusive or fraudulent)

Entities engaging with WHO are expected to ensure that the conduct of their employees and any other persons engaged by them to perform any activities or to provide any services for WHO on behalf of the entities is consistent with the WHO standards of conduct. In particular, WHO has zero tolerance towards any form of sexual misconduct, which includes sexual exploitation, sexual abuse, sexual violence, and sexual harassment, and other types of abusive or fraudulent conduct. In the view of the forgoing, please confirm that your entity shall:

Take all reasonable and appropriate measures to prevent sexual misconduct as defined in WHO’s Policy on Preventing and Addressing Sexual Misconduct, and other types of abusive or fraudulent conduct as defined, respectively, in WHO’s Policy on Preventing and Addressing Abusive Conduct and in WHO’s Policy on Prevention, Detection and Response to Fraud and Corruption by any of its employees and by any other persons engaged by it to perform any activities or to provide any services for WHO on the entity’s behalf;

Promptly report to WHO’s Office of Internal Oversight Services (IOS) at investigation@who.int any actual or suspected misconduct, as defined by WHO in these Policies and of which the entity becomes aware;

Promptly communicate to IOS any measures that may be necessary or appropriate to protect the confidentiality and wellbeing of the alleged victim;

Promptly respond to any actual or suspected misconduct as defined by WHO in these Policies of which the entity becomes aware; and

To cooperate with IOS and keep IOS informed of the status and outcome of any measures of protection, corrections to operations, investigation, and disciplinary action taken against any perpetrator by the entity.

Date submitted